1. Home
  2. POCI vs GOSS Comparison

POCI vs GOSS Comparison

Compare POCI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$5.75

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.16

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POCI
GOSS
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
41.7M
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
POCI
GOSS
Price
$5.75
$0.16
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
74.6K
14.0M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,091,269.00
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$201.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.15
52 Week High
$6.04
$3.87

Technical Indicators

Market Signals
Indicator
POCI
GOSS
Relative Strength Index (RSI) 66.58 24.49
Support Level $3.99 N/A
Resistance Level $6.04 $0.36
Average True Range (ATR) 0.39 0.02
MACD 0.03 0.00
Stochastic Oscillator 78.88 1.86

Price Performance

Historical Comparison
POCI
GOSS

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: